BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9882439)

  • 1. Studies of the role of the integrin EF-hand, Ca2+-binding sites in glycosylphosphatidylinositol-specific phospholipase D: reduced expression following mutagenesis of residues predicted to bind Ca2+.
    Li JY; Low MG
    Arch Biochem Biophys; 1999 Jan; 361(1):142-8. PubMed ID: 9882439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midportion antibodies stimulate glycosylphosphatidylinositol-specific phospholipase D activity.
    Deeg MA; Bowen RF
    Arch Biochem Biophys; 1999 Oct; 370(2):278-84. PubMed ID: 10510287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the plasma glycosylphosphatidylinositol-specific phospholipase D by synthetic analogs of lipid A and phosphatidic acid.
    Low MG; Stütz P
    Arch Biochem Biophys; 1999 Nov; 371(2):332-9. PubMed ID: 10545222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-mouse GPI-PLD antisera highlight structural differences between murine and bovine GPI-PLDs.
    Gregory P; Ziemiecki A; Zürcher G; Brodbeck U; Bütikofer P
    Biol Chem; 2003 Dec; 384(12):1575-82. PubMed ID: 14719799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro phosphorylation of purified glycosylphosphatidylinositol-specific phospholipase D.
    Civenni G; Bütikofer P; Stadelmann B; Brodbeck U
    Biol Chem; 1999 May; 380(5):585-8. PubMed ID: 10384965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutating His29, His125, His133 or His158 abolishes glycosylphosphatidylinositol-specific phospholipase D catalytic activity.
    Raikwar NS; Bowen RF; Deeg MA
    Biochem J; 2005 Oct; 391(Pt 2):285-9. PubMed ID: 15943582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural features of GPI-specific phospholipase D revealed by proteolytic fragmentation and Ca2+ binding studies.
    Li JY; Hollfelder K; Huang KS; Low MG
    J Biol Chem; 1994 Nov; 269(46):28963-71. PubMed ID: 7961859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways.
    Jeon ES; Kang YJ; Song HY; Im DS; Kim HS; Ryu SH; Kim YK; Kim JH
    Cell Signal; 2005 Jun; 17(6):777-87. PubMed ID: 15722202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium binding to the class I alpha-1,2-mannosidase from Saccharomyces cerevisiae occurs outside the EF hand motif.
    Lipari F; Herscovics A
    Biochemistry; 1999 Jan; 38(3):1111-8. PubMed ID: 9894008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a phosphoinositide binding motif that mediates activation of mammalian and yeast phospholipase D isoenzymes.
    Sciorra VA; Rudge SA; Prestwich GD; Frohman MA; Engebrecht J; Morris AJ
    EMBO J; 1999 Nov; 18(21):5911-21. PubMed ID: 10545103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of calcineurin A subunit phosphatase activity by its calcium-binding B subunit.
    Watanabe Y; Perrino BA; Soderling TR
    Biochemistry; 1996 Jan; 35(2):562-6. PubMed ID: 8555228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.
    Wilhelm OG; Wilhelm S; Escott GM; Lutz V; Magdolen V; Schmitt M; Rifkin DB; Wilson EL; Graeff H; Brunner G
    J Cell Physiol; 1999 Aug; 180(2):225-35. PubMed ID: 10395292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
    Raikwar NS; Cho WK; Bowen RF; Deeg MA
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distant evolutionary relationship between GPI-specific phospholipase D and bacterial phosphatidylcholine-preferring phospholipase C.
    Rigden DJ
    FEBS Lett; 2004 Jul; 569(1-3):229-34. PubMed ID: 15225639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylphosphatidylinositol-specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes.
    Larson DM; Kennedy MA; Bowen RF; Verchere CB; Deeg MA
    J Pathol; 2004 Aug; 203(4):961-7. PubMed ID: 15259000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metal-binding loop mutations on ligand binding to calcium- and integrin-binding protein 1. Evolution of the EF-hand?
    Yamniuk AP; Gifford JL; Linse S; Vogel HJ
    Biochemistry; 2008 Feb; 47(6):1696-707. PubMed ID: 18197701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interconversion of the ligand arrays in the CD and EF sites of oncomodulin. Influence on Ca2+-binding affinity.
    Henzl MT; Hapak RC; Likos JJ
    Biochemistry; 1998 Jun; 37(25):9101-11. PubMed ID: 9636056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important roles of glycosylphosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma.
    Tang JH; He WJ; Huang H; Tan CC; Duan Q; Wang KJ; Yuan XY; Zhu XJ
    Clin Biochem; 2009 Mar; 42(4-5):400-7. PubMed ID: 19135435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the GPI pre-anchor sequence in human p97--a general approach for generating the soluble form of GPI-linked proteins.
    Yang J; Tiong J; Kennard M; Jefferies WA
    Protein Expr Purif; 2004 Mar; 34(1):28-48. PubMed ID: 14766298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D.
    Flores-Borja F; Kieszkievicz J; Church V; Francis-West PH; Schofield J; Rademacher TW; Lund T
    Biochimie; 2004; 86(4-5):275-82. PubMed ID: 15194230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.